Lloyd Price

SEPTEMBER 16, 2023

Exec Summary: Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. The company raised $10m in 2022. This represents a year-on-year increase of 12%. Resolution Therapeutics is a spin-out of the University of Edinburgh.

Life Science 63

Life Science Digital Health BioTech Health Technology 63

Lloyd Price

FEBRUARY 13, 2024

Source: [link] Scotland's top ten tech start-ups - HealthTech related companies Investment into the Scottish healthtech market in 2022 reached a record high of £705 million, surpassing the previous record of £626 million set in 2021. At the top is Glasgow-based Amphista Therapeutics, which raised $50m in 2022.

Healthcare Innovation 61

Healthcare Innovation Digital Health Life Science healthcare technology 61

Lloyd Price

SEPTEMBER 2, 2023

Exec Summary: The European HealthTech M&A market is expected to remain active in 2023, albeit with some slowdown from the record-breaking levels seen in 2022. This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies.

Life Science 61

Life Science Digital Health EHR BioTech 61

Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. 2 Digital health is a large (+$900bn by 2032) and growing (13.6%

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88